A re-evaluation of the decamethonium test for myasthenia gravis.
D000200:Action Potentials / Q000187:drug effects*; D001984:Bronchial Neoplasms / Q000150:complications; D003650:Decamethonium Compounds / Q000008:administration & dosage / Q000494:pharmacology; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004491:Edrophonium / Q000494:pharmacology; D004576:Electromyography; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008722:Methods; D009132:Muscles / Q000187:drug effects; D009157:Myasthenia Gravis / Q000150:complications / Q000175:diagnosis*; D009388:Neostigmine / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects
D003650:Decamethonium Compounds; D009388:Neostigmine; D004491:Edrophonium